Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient
To report a case of reduced duration of action of rocuronium in a patient with normocalcemic hyperparathyroidism (HPT). A 56-yr-old patient with primary HPT, who had had surgical resection of three and a half parathyroid glands nine months previously, was referred to our institution for further inve...
Gespeichert in:
Veröffentlicht in: | Canadian journal of anesthesia 2003-06, Vol.50 (6), p.558-561 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 561 |
---|---|
container_issue | 6 |
container_start_page | 558 |
container_title | Canadian journal of anesthesia |
container_volume | 50 |
creator | MUNIR, Muhammad A JAFFAR, Muhammad ARSHAD, Muhammad AKHTER, M. Shahab JUNMING ZHANG |
description | To report a case of reduced duration of action of rocuronium in a patient with normocalcemic hyperparathyroidism (HPT).
A 56-yr-old patient with primary HPT, who had had surgical resection of three and a half parathyroid glands nine months previously, was referred to our institution for further investigation of a persistent increase in parathyroid hormone. Preoperatively, the patient had a normal serum ionized and total calcium. The patient was diagnosed with a persistent parathyroid adenoma and was scheduled for an elective parathyroidectomy. General anesthesia was induced with iv propofol, fentanyl and succinylcholine. Intraoperatively, anesthesia was maintained with nitrous oxide in oxygen, and isoflurane. Neuromuscular blockade was attained using incremental doses of rocuronium. The average duration of 0.15 mg x kg(-1) incremental doses of rocuronium was 5.9 min (expected: 13-18 min), and that of 0.2 mg x kg(-1) was ten minutes (expected: 19-23 min).
Primary HPT even in the absence of hypercalcemia may result in resistance to competitive blockade by rocuronium. It suggests that primary HPT may cause acetylcholine receptor up-regulation resulting in hyposensitivity to non-depolarizing muscle relaxants. |
doi_str_mv | 10.1007/BF03018640 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73400155</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73400155</sourcerecordid><originalsourceid>FETCH-LOGICAL-c376t-56d90979aba6b378d86263c49a045e26cc891859675b0911a3db65a770da4c743</originalsourceid><addsrcrecordid>eNpd0E1r3DAQBmBRUppNmkt_QBGF5FBwOrKsr2MSkrQQKIQUejNjScsq2JYrWTT77-OwCws5DQzPvAwvIV8YXDIA9eP6DjgwLRv4QFasMbLSRokjsgLN60oy-HtMTnJ-BgAthf5EjlmtaykauSL46F2x3lFXEs4hjjSu6VCy7T1NvseX3fJ_mDc0RVtSHEMZaBgp0jGmIVrsrR-CpZvt5NOES8pmm2JwdFpO_Th_Jh_X2Gd_tp-n5M_d7dPNz-rh9_2vm6uHynIl50pIZ8Aogx3KjivttKwlt41BaISvpbXaMC2MVKIDwxhy10mBSoHDxqqGn5KLXe6U4r_i89wOIVvf9zj6WHKreAPAhFjgt3fwOZY0Lr-1WjOuBBNqQd93yKaYc_LrdkphwLRtGbRvrbeH1hf8dZ9YusG7A93XvIDzPcC8FLZOONqQD06wWtZa8FeiK4lX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>881375157</pqid></control><display><type>article</type><title>Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>MUNIR, Muhammad A ; JAFFAR, Muhammad ; ARSHAD, Muhammad ; AKHTER, M. Shahab ; JUNMING ZHANG</creator><creatorcontrib>MUNIR, Muhammad A ; JAFFAR, Muhammad ; ARSHAD, Muhammad ; AKHTER, M. Shahab ; JUNMING ZHANG</creatorcontrib><description>To report a case of reduced duration of action of rocuronium in a patient with normocalcemic hyperparathyroidism (HPT).
A 56-yr-old patient with primary HPT, who had had surgical resection of three and a half parathyroid glands nine months previously, was referred to our institution for further investigation of a persistent increase in parathyroid hormone. Preoperatively, the patient had a normal serum ionized and total calcium. The patient was diagnosed with a persistent parathyroid adenoma and was scheduled for an elective parathyroidectomy. General anesthesia was induced with iv propofol, fentanyl and succinylcholine. Intraoperatively, anesthesia was maintained with nitrous oxide in oxygen, and isoflurane. Neuromuscular blockade was attained using incremental doses of rocuronium. The average duration of 0.15 mg x kg(-1) incremental doses of rocuronium was 5.9 min (expected: 13-18 min), and that of 0.2 mg x kg(-1) was ten minutes (expected: 19-23 min).
Primary HPT even in the absence of hypercalcemia may result in resistance to competitive blockade by rocuronium. It suggests that primary HPT may cause acetylcholine receptor up-regulation resulting in hyposensitivity to non-depolarizing muscle relaxants.</description><identifier>ISSN: 0832-610X</identifier><identifier>EISSN: 1496-8975</identifier><identifier>DOI: 10.1007/BF03018640</identifier><identifier>PMID: 12826546</identifier><identifier>CODEN: CJOAEP</identifier><language>eng</language><publisher>Toronto, ON: Canadian Anesthesiologists' Society</publisher><subject>Androstanols - pharmacology ; Anesthesia ; Anesthetics. Neuromuscular blocking agents ; Biological and medical sciences ; Female ; Humans ; Medical sciences ; Middle Aged ; Muscle Relaxation - drug effects ; Neuromuscular Nondepolarizing Agents - pharmacology ; Neuropharmacology ; Pharmacology. Drug treatments ; Receptors, Cholinergic - analysis ; Receptors, Cholinergic - drug effects ; Time Factors</subject><ispartof>Canadian journal of anesthesia, 2003-06, Vol.50 (6), p.558-561</ispartof><rights>2003 INIST-CNRS</rights><rights>Canadian Anesthesiologists 2003.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c376t-56d90979aba6b378d86263c49a045e26cc891859675b0911a3db65a770da4c743</citedby><cites>FETCH-LOGICAL-c376t-56d90979aba6b378d86263c49a045e26cc891859675b0911a3db65a770da4c743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15126285$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12826546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MUNIR, Muhammad A</creatorcontrib><creatorcontrib>JAFFAR, Muhammad</creatorcontrib><creatorcontrib>ARSHAD, Muhammad</creatorcontrib><creatorcontrib>AKHTER, M. Shahab</creatorcontrib><creatorcontrib>JUNMING ZHANG</creatorcontrib><title>Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient</title><title>Canadian journal of anesthesia</title><addtitle>Can J Anaesth</addtitle><description>To report a case of reduced duration of action of rocuronium in a patient with normocalcemic hyperparathyroidism (HPT).
A 56-yr-old patient with primary HPT, who had had surgical resection of three and a half parathyroid glands nine months previously, was referred to our institution for further investigation of a persistent increase in parathyroid hormone. Preoperatively, the patient had a normal serum ionized and total calcium. The patient was diagnosed with a persistent parathyroid adenoma and was scheduled for an elective parathyroidectomy. General anesthesia was induced with iv propofol, fentanyl and succinylcholine. Intraoperatively, anesthesia was maintained with nitrous oxide in oxygen, and isoflurane. Neuromuscular blockade was attained using incremental doses of rocuronium. The average duration of 0.15 mg x kg(-1) incremental doses of rocuronium was 5.9 min (expected: 13-18 min), and that of 0.2 mg x kg(-1) was ten minutes (expected: 19-23 min).
Primary HPT even in the absence of hypercalcemia may result in resistance to competitive blockade by rocuronium. It suggests that primary HPT may cause acetylcholine receptor up-regulation resulting in hyposensitivity to non-depolarizing muscle relaxants.</description><subject>Androstanols - pharmacology</subject><subject>Anesthesia</subject><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Muscle Relaxation - drug effects</subject><subject>Neuromuscular Nondepolarizing Agents - pharmacology</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Receptors, Cholinergic - analysis</subject><subject>Receptors, Cholinergic - drug effects</subject><subject>Time Factors</subject><issn>0832-610X</issn><issn>1496-8975</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpd0E1r3DAQBmBRUppNmkt_QBGF5FBwOrKsr2MSkrQQKIQUejNjScsq2JYrWTT77-OwCws5DQzPvAwvIV8YXDIA9eP6DjgwLRv4QFasMbLSRokjsgLN60oy-HtMTnJ-BgAthf5EjlmtaykauSL46F2x3lFXEs4hjjSu6VCy7T1NvseX3fJ_mDc0RVtSHEMZaBgp0jGmIVrsrR-CpZvt5NOES8pmm2JwdFpO_Th_Jh_X2Gd_tp-n5M_d7dPNz-rh9_2vm6uHynIl50pIZ8Aogx3KjivttKwlt41BaISvpbXaMC2MVKIDwxhy10mBSoHDxqqGn5KLXe6U4r_i89wOIVvf9zj6WHKreAPAhFjgt3fwOZY0Lr-1WjOuBBNqQd93yKaYc_LrdkphwLRtGbRvrbeH1hf8dZ9YusG7A93XvIDzPcC8FLZOONqQD06wWtZa8FeiK4lX</recordid><startdate>20030601</startdate><enddate>20030601</enddate><creator>MUNIR, Muhammad A</creator><creator>JAFFAR, Muhammad</creator><creator>ARSHAD, Muhammad</creator><creator>AKHTER, M. Shahab</creator><creator>JUNMING ZHANG</creator><general>Canadian Anesthesiologists' Society</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20030601</creationdate><title>Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient</title><author>MUNIR, Muhammad A ; JAFFAR, Muhammad ; ARSHAD, Muhammad ; AKHTER, M. Shahab ; JUNMING ZHANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c376t-56d90979aba6b378d86263c49a045e26cc891859675b0911a3db65a770da4c743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Androstanols - pharmacology</topic><topic>Anesthesia</topic><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Muscle Relaxation - drug effects</topic><topic>Neuromuscular Nondepolarizing Agents - pharmacology</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Receptors, Cholinergic - analysis</topic><topic>Receptors, Cholinergic - drug effects</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MUNIR, Muhammad A</creatorcontrib><creatorcontrib>JAFFAR, Muhammad</creatorcontrib><creatorcontrib>ARSHAD, Muhammad</creatorcontrib><creatorcontrib>AKHTER, M. Shahab</creatorcontrib><creatorcontrib>JUNMING ZHANG</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business & Current Affairs Database</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Canadian journal of anesthesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MUNIR, Muhammad A</au><au>JAFFAR, Muhammad</au><au>ARSHAD, Muhammad</au><au>AKHTER, M. Shahab</au><au>JUNMING ZHANG</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient</atitle><jtitle>Canadian journal of anesthesia</jtitle><addtitle>Can J Anaesth</addtitle><date>2003-06-01</date><risdate>2003</risdate><volume>50</volume><issue>6</issue><spage>558</spage><epage>561</epage><pages>558-561</pages><issn>0832-610X</issn><eissn>1496-8975</eissn><coden>CJOAEP</coden><abstract>To report a case of reduced duration of action of rocuronium in a patient with normocalcemic hyperparathyroidism (HPT).
A 56-yr-old patient with primary HPT, who had had surgical resection of three and a half parathyroid glands nine months previously, was referred to our institution for further investigation of a persistent increase in parathyroid hormone. Preoperatively, the patient had a normal serum ionized and total calcium. The patient was diagnosed with a persistent parathyroid adenoma and was scheduled for an elective parathyroidectomy. General anesthesia was induced with iv propofol, fentanyl and succinylcholine. Intraoperatively, anesthesia was maintained with nitrous oxide in oxygen, and isoflurane. Neuromuscular blockade was attained using incremental doses of rocuronium. The average duration of 0.15 mg x kg(-1) incremental doses of rocuronium was 5.9 min (expected: 13-18 min), and that of 0.2 mg x kg(-1) was ten minutes (expected: 19-23 min).
Primary HPT even in the absence of hypercalcemia may result in resistance to competitive blockade by rocuronium. It suggests that primary HPT may cause acetylcholine receptor up-regulation resulting in hyposensitivity to non-depolarizing muscle relaxants.</abstract><cop>Toronto, ON</cop><pub>Canadian Anesthesiologists' Society</pub><pmid>12826546</pmid><doi>10.1007/BF03018640</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0832-610X |
ispartof | Canadian journal of anesthesia, 2003-06, Vol.50 (6), p.558-561 |
issn | 0832-610X 1496-8975 |
language | eng |
recordid | cdi_proquest_miscellaneous_73400155 |
source | MEDLINE; SpringerLink Journals |
subjects | Androstanols - pharmacology Anesthesia Anesthetics. Neuromuscular blocking agents Biological and medical sciences Female Humans Medical sciences Middle Aged Muscle Relaxation - drug effects Neuromuscular Nondepolarizing Agents - pharmacology Neuropharmacology Pharmacology. Drug treatments Receptors, Cholinergic - analysis Receptors, Cholinergic - drug effects Time Factors |
title | Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T11%3A39%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20duration%20of%20muscle%20relaxation%20with%20rocuronium%20in%20a%20normocalcemic%20hyperparathyroid%20patient&rft.jtitle=Canadian%20journal%20of%20anesthesia&rft.au=MUNIR,%20Muhammad%20A&rft.date=2003-06-01&rft.volume=50&rft.issue=6&rft.spage=558&rft.epage=561&rft.pages=558-561&rft.issn=0832-610X&rft.eissn=1496-8975&rft.coden=CJOAEP&rft_id=info:doi/10.1007/BF03018640&rft_dat=%3Cproquest_cross%3E73400155%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=881375157&rft_id=info:pmid/12826546&rfr_iscdi=true |